Advertisement

Legal & Regulatory Issues

Members of the U.S. Senate Committee on Health, Education, Labor and Pensions sent a letter Aug. 6 to Acting Attorney General Todd Blanche seeking an update on the criminal contempt referral against former Dallas-based Steward Health Care Chairman and CEO…

Hartford, Conn.-based Connecticut Children’s Medical Center has agreed to stop performing gender-affirming procedures on minors as part of agreements with the Department of Justice. Under the agreement, Connecticut Children’s committed to not administering puberty blockers or cross-sex hormones, or performing…

Barbara Ann Karmanos Cancer Hospital in Detroit has filed a lawsuit against Tenet Healthcare’s Detroit Medical Center and several of its affiliated hospitals, alleging DMC threatened to scale back or terminate services critical to Karmanos’ operations amid a long-running contract…

Luigi Mangione’s defense team is challenging media access restrictions for his upcoming New York state murder trial, arguing they violate his constitutional right to a public proceeding and demanding that the court broadcast the trial live. In a July 31…

Twenty-five states are suing the Trump administration to halt the latest round of global tariffs that took effect July 24.  Five things to know:   1. Duties ranging from roughly 10% to 12.5% took effect on imports from more than 80…

Advertisement

Five federal employees are suing U.S. Office of Personnel Management Director Scott Kupor over alleged sex discrimination due to the rollback of coverage for gender-affirming care. Plaintiffs, backed by the Human Rights Campaign Foundation, filed the lawsuit Aug. 3 in…

A coalition of 22 states is suing to block key pieces of CMS’ 2027 ACA marketplace rule, arguing the changes will push consumers into “barebones” coverage and revive provisions a federal court previously struck down. The complaint, filed July 31…

The U.S. tariff landscape has shifted dramatically in 2026, and healthcare is caught in the middle. From a landmark Supreme Court ruling to new duties on branded drugs, the policy environment has moved fast and shows no signs of settling.…

Advertisement